Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 9
2001 6
2002 7
2003 15
2004 15
2005 19
2006 18
2007 25
2008 36
2009 48
2010 39
2011 53
2012 64
2013 62
2014 75
2015 75
2016 100
2017 71
2018 51
2019 28
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

669 results
Results by year
Filters applied: . Clear all
Page 1
Sexual dysfunction in female patients with relapsing-remitting multiple sclerosis.
Bartnik P, et al. Brain Behav 2017. PMID 28638707 Free PMC article.
INTRODUCTION: Sexual dysfunction (SD) is one of the common symptoms of multiple sclerosis (MS) and is often underdiagnosed, especially in women. Relapsing-remitting multiple sclerosis (RRMS) is the most widespread form of the disease, but the data on SD occurrence in this particular group of patients is limited. ...
INTRODUCTION: Sexual dysfunction (SD) is one of the common symptoms of multiple sclerosis (MS) and is often underdiagnosed, es …
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis.
Landi D, et al. J Neurol Neurosurg Psychiatry 2018 - Clinical Trial. PMID 29970387
OBJECTIVE: To investigate clinical and radiological outcomes of women with relapsing-remitting multiple sclerosis (RRMS) undergoing abortion. ...
OBJECTIVE: To investigate clinical and radiological outcomes of women with relapsing-remitting multiple sclerosis
Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review.
Kalincik T. Neuroepidemiology 2015 - Review. PMID 25997994 Free article.
Relapses (episodic exacerbations of neurological signs or symptoms) are a defining feature of relapsing-remitting multiple sclerosis (MS), the most prevalent MS phenotype. ...Other areas of research include pathophysiology and determinants of relapse incidence, recurrence and phenotypes, including the characteristics of the relapsing and non-relapsing multiple sclerosis variants and their responsiveness to therapies....
Relapses (episodic exacerbations of neurological signs or symptoms) are a defining feature of relapsing-remitting multiple
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study).
Comi G, et al. J Neurol 2017 - Clinical Trial. PMID 29063244 Free PMC article.
Cognitive impairment (CI) affects 40-65% of multiple sclerosis (MS) patients. This study attempted evaluating the effects of fingolimod and interferon beta-1b (IFN β-1b) on CI progression, magnetic resonance imaging (MRI) and clinical outcomes in relapsing-remitting MS (RRMS) patients over 18 months. ...
Cognitive impairment (CI) affects 40-65% of multiple sclerosis (MS) patients. This study attempted evaluating the effects of f …
Subclinical cochlear dysfunction in newly diagnosed relapsing-remitting multiple sclerosis.
Di Mauro R, et al. Mult Scler Relat Disord 2019. PMID 31154261
BACKGROUND: Hearing impairment in multiple sclerosis has long been considered a process mainly related to the central auditory system. ...METHODS: Forty patients with newly diagnosed relapsing-remitting multiple sclerosis, clinically normal hearing and no brainstem lesions (study group) and forty matched controls (control group) were included in the study. ...
BACKGROUND: Hearing impairment in multiple sclerosis has long been considered a process mainly related to the central auditory …
Structural correlates for fatigue in early relapsing remitting multiple sclerosis.
Wilting J, et al. Eur Radiol 2016. PMID 26026721
OBJECTIVES: Fatigue is a common symptom in multiple sclerosis (MS) patients, even early in the disease, but the pathophysiology remains unclear. We aimed to determine morphologic and microstructural correlates and neuropsychological parameters of cognitive fatigue in early relapsing-remitting MS patients. ...
OBJECTIVES: Fatigue is a common symptom in multiple sclerosis (MS) patients, even early in the disease, but the pathophysiolog …
Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
Hojjat SP, et al. AJNR Am J Neuroradiol 2016. PMID 27012299 Free PMC article.
BACKGROUND AND PURPOSE: The role of gray matter in multiple sclerosis is increasingly evident; however, conventional images demonstrate limitations in cortical lesion identification. ...White matter lesion but not cortical lesion perfusion was significantly reduced in cognitively impaired patients with relapsing-remitting MS versus unimpaired patients with relapsing-remitting MS. ...
BACKGROUND AND PURPOSE: The role of gray matter in multiple sclerosis is increasingly evident; however, conventional images de …
Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial.
Ozakbas S, et al. Mult Scler Relat Disord 2018 - Clinical Trial. PMID 29605801
BACKGROUND: Cognitive impairment (CI) is a common problem in multiple sclerosis (MS), may occur either in early or late phase of the disease, and impairs quality of life. OBJECTIVES: This study aimed to determine the prevalence of CI and related risk factors in relapsing-remitting MS (RRMS) patients in Turkey. ...
BACKGROUND: Cognitive impairment (CI) is a common problem in multiple sclerosis (MS), may occur either in early or late phase …
Pilates exercise training vs. physical therapy for improving walking and balance in people with multiple sclerosis: a randomized controlled trial.
Kalron A, et al. Clin Rehabil 2017 - Clinical Trial. PMID 26951348
SETTING: Multiple Sclerosis Center, Sheba Medical Center, Tel-Hashomer, Israel. SUBJECTS: Forty-five people with multiple sclerosis, 29 females, mean age (SD) was 43.2 (11.6) years; mean Expanded Disability Status Scale (S.D) was 4.3 (1.3). ...In addition, the following self-report forms included the Multiple Sclerosis Walking Scale and Modified Fatigue Impact Scale. ...
SETTING: Multiple Sclerosis Center, Sheba Medical Center, Tel-Hashomer, Israel. SUBJECTS: Forty-five people with multiple
Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
Moccia M, et al. J Neurol 2015. PMID 25673130
Uric acid (UA) is reduced in multiple sclerosis (MS), and possibly relates to MS outcomes, with lower UA levels in subjects experiencing a relapse or presenting higher disability scores. ...We included 141 subjects with relapsing-remitting MS (RRMS) and performed expanded disability status scale (EDSS), symbol digit modalities test (SDMT) and UA evaluation at baseline visit and after 2-year follow-up. ...
Uric acid (UA) is reduced in multiple sclerosis (MS), and possibly relates to MS outcomes, with lower UA levels in subjects ex …
669 results
Jump to page
Feedback